BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Treatment
67 results:

  • 1. Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
    Steadman JA; Glasgow AE; Neequaye NN; Habermann EB; Hieken TJ
    J Surg Oncol; 2024 May; 129(6):1041-1050. PubMed ID: 38436625
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploration of genetic characterization in hyperprogressive disease after immunotherapy retreatment in a patient with LCNEC: A case report.
    Zhang Y; Yang J; Shao T; Chen J; Shu Q; Shou L
    Hum Vaccin Immunother; 2024 Dec; 20(1):2313281. PubMed ID: 38348622
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Longitudinal Natural History Study of Children and Adults with Rare Solid tumors: Initial Results for First 200 Participants.
    Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
    Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and ctnnb1 mutations.
    Tsushima N; Kano S; Hatanaka KC; Suzuki T; Hamada S; Idogawa H; Nakamaru Y; Suzuki M; Hatanaka Y; Homma A
    Auris Nasus Larynx; 2024 Apr; 51(2):313-319. PubMed ID: 37953090
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC.
    Zheng SX; Chen J; Zhuang BB; Zhang Q; Shi SS; Zhang GL
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16055-16067. PubMed ID: 37695389
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect and timing of operative treatment for teratoma associated N-Methyl-d-Aspartate receptor-antibody encephalitis: A systematic review with meta-analysis.
    Erlebach R; Brandi G
    J Neuroimmunol; 2023 Sep; 382():578153. PubMed ID: 37499300
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Craniopharyngioma in Pediatrics and Adults.
    Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
    Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Craniopharyngioma-An update on metabolic and cognitive complications and new therapy.
    Erfurth EM
    J Intern Med; 2023 Sep; 294(3):269-280. PubMed ID: 37424210
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
    Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
    Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Liu Z; Fang B; Cao J; Zhou Q; Zhu F; Fan L; Xue L; Huang C; Bo H
    Bioengineered; 2022 May; 13(5):12141-12155. PubMed ID: 35575252
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation.
    Huang RSP; Tse JY; Harries L; Graf RP; Lin DI; Murugesan K; Hiemenz MC; Parimi V; Janovitz T; Decker B; Severson E; Levy MA; Ramkissoon SH; Elvin JA; Ross JS; Williams EA
    Oncologist; 2022 Aug; 27(8):655-662. PubMed ID: 35552752
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
    Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
    Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeted Therapy in the Management of Modern Craniopharyngiomas.
    Reyes M; Taghvaei M; Yu S; Sathe A; Collopy S; Prashant GN; Evans JJ; Karsy M
    Front Biosci (Landmark Ed); 2022 Apr; 27(4):136. PubMed ID: 35468695
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeted therapies in the medical management of craniopharyngioma.
    Iglesias P
    Pituitary; 2022 Jun; 25(3):383-392. PubMed ID: 35301645
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Detection of Melanogenesis and Anti-Apoptosis-Associated Melanoma Factors: Array CGH and PPI Mapping Integrating Study.
    Yin SJ; Qian GY; Yang JM; Lee J; Park YD
    Protein Pept Lett; 2021; 28(12):1408-1424. PubMed ID: 34749602
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Recurrent Wnt medulloblastoma treated with marrow-ablative chemotherapy and autologous hematopoietic progenitor cell rescue: a dual case report and review of the literature.
    Harris MK; Shatara M; Funk Z; Stanek J; Boué DR; Jones J; Finlay JL; Abdelbaki MS
    Childs Nerv Syst; 2022 Feb; 38(2):465-472. PubMed ID: 33948723
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    Gajjar A; Robinson GW; Smith KS; Lin T; Merchant TE; Chintagumpala M; Mahajan A; Su J; Bouffet E; Bartels U; Schechter T; Hassall T; Robertson T; Nicholls W; Gururangan S; Schroeder K; Sullivan M; Wheeler G; Hansford JR; Kellie SJ; McCowage G; Cohn R; Fisher MJ; Krasin MJ; Stewart CF; Broniscer A; Buchhalter I; Tatevossian RG; Orr BA; Neale G; Klimo P; Boop F; Srinivasan A; Pfister SM; Gilbertson RJ; Onar-Thomas A; Ellison DW; Northcott PA
    J Clin Oncol; 2021 Mar; 39(7):822-835. PubMed ID: 33405951
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries.
    Rocha CRR; Reily Rocha A; Molina Silva M; Rodrigues Gomes L; Teatin Latancia M; Andrade Tomaz M; de Souza I; Karolynne Seregni Monteiro L; Menck CFM
    Cells; 2020 Dec; 9(12):. PubMed ID: 33271924
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.
    Petralia F; Tignor N; Reva B; Koptyra M; Chowdhury S; Rykunov D; Krek A; Ma W; Zhu Y; Ji J; Calinawan A; Whiteaker JR; Colaprico A; Stathias V; Omelchenko T; Song X; Raman P; Guo Y; Brown MA; Ivey RG; Szpyt J; Guha Thakurta S; Gritsenko MA; Weitz KK; Lopez G; Kalayci S; Gümüş ZH; Yoo S; da Veiga Leprevost F; Chang HY; Krug K; Katsnelson L; Wang Y; Kennedy JJ; Voytovich UJ; Zhao L; Gaonkar KS; Ennis BM; Zhang B; Baubet V; Tauhid L; Lilly JV; Mason JL; Farrow B; Young N; Leary S; Moon J; Petyuk VA; Nazarian J; Adappa ND; Palmer JN; Lober RM; Rivero-Hinojosa S; Wang LB; Wang JM; Broberg M; Chu RK; Moore RJ; Monroe ME; Zhao R; Smith RD; Zhu J; Robles AI; Mesri M; Boja E; Hiltke T; Rodriguez H; Zhang B; Schadt EE; Mani DR; Ding L; Iavarone A; Wiznerowicz M; Schürer S; Chen XS; Heath AP; Rokita JL; Nesvizhskii AI; Fenyö D; Rodland KD; Liu T; Gygi SP; Paulovich AG; Resnick AC; Storm PB; Rood BR; Wang P; ;
    Cell; 2020 Dec; 183(7):1962-1985.e31. PubMed ID: 33242424
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.